BENEV Company Inc ’s Post

We sat down with industry leader, Dr. David Goldberg, to get his thoughts on the incredible BENEV portfolio and his experience. #benevinseoul #benevfamily #benefiteveryone *EXOSOME Disclaimer: BENEV Exosome products powered by Exo-SCRT™ are post care “topical use” cosmetic solutions. The isolated and purified exosomes in both products have been accepted by the PCPC, and International Cosmetic Ingredient Nomenclature Committee (INC), and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as INCI book. There are at this time no other cosmetic INCI name(s) assigned to exosome products in the market prior to this accomplishment. These products are not drug products. They are not intended to prevent, treat or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously. *Disclaimer: Sylfirm X is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. (K200185) *Miracu® Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. FDA 510K #K172602. The Miracu barbed surgical suture is comprised of dyed polydioxanone, is indicated for soft tissue approximation where use of an absorbable suture is appropriate. The anatomical locations of use are on the skin for dermatological applications only. The suture is not intended for interior body cavity applications and the suture is not intended for lifting and supporting tissues. *Viviscal Disclaimer: These statements have not been reviewed by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new supplement, especially if you have any pre-existing medical conditions or are taking other medications.

A huge shout out to one of our incredible KOLs and long-term physician partners, Dr. Joelle Lieman! We sat down with her to discuss what her experience has been like working with BENEV and what new developments she is excited to see from us as we embark on new research opportunities with some NEW and exciting technologies! #benevinseoul #benevfamily #benefiteveryone *EXOSOME Disclaimer: BENEV Exosome products powered by Exo-SCRT™ are post care “topical use” cosmetic solutions. The isolated and purified exosomes in both products have been accepted by the PCPC, and International Cosmetic Ingredient Nomenclature Committee (INC), and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as INCI book. There are at this time no other cosmetic INCI name(s) assigned to exosome products in the market prior to this accomplishment. These products are not drug products. They are not intended to prevent, treat or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously. *Disclaimer: Sylfirm X is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. (K200185) *Miracu® Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. FDA 510K #K172602. The Miracu barbed surgical suture is comprised of dyed polydioxanone, is indicated for soft tissue approximation where use of an absorbable suture is appropriate. The anatomical locations of use are on the skin for dermatological applications only. The suture is not intended for interior body cavity applications and the suture is not intended for lifting and supporting tissues. *Viviscal PRO Disclaimer: These statements have not been reviewed by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new supplement, especially if you have any pre-existing medical conditions or are taking other medications.

See inside what it is like to attend a Forging the Future of Aesthetics event with us! These events are all about diving into clinical pearls and understanding new combination therapies that our BENEV Regenerative Portfolio can bring to your practice. #benev #benevskinscience #forgingthefutureofaesthetics *EXOSOME Disclaimer: BENEV Exosome products powered by Exo-SCRT™ are post care “topical use” cosmetic solutions. The isolated and purified exosomes in both products have been accepted by the PCPC, and International Cosmetic Ingredient Nomenclature Committee (INC), and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as INCI book. There are at this time no other cosmetic INCI name(s) assigned to exosome products in the market prior to this accomplishment. These products are not drug products. They are not intended to prevent, treat or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously. *Disclaimer: Sylfirm X is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. (K200185) *Miracu® Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. FDA 510K #K172602. The Miracu barbed surgical suture is comprised of dyed polydioxanone, is indicated for soft tissue approximation where use of an absorbable suture is appropriate. The anatomical locations of use are on the skin for dermatological applications only. The suture is not intended for interior body cavity applications and the suture is not intended for lifting and supporting tissues.

"Everyday is the beginning of another new stage, where you have to decide to trust in what has been done"... At True Node Sciences, Inc., we're excited about the potential that statins hold for improving oral health. Back in 2021, we decided to advance our PGR-1 technology for treating mucosal inflammatory conditions like periodontitis, inspired by our own research. Since then, even more studies—like the following article—have shown how statins contribute to oral health in various ways, including: • Accelerating wound healing • Promoting bone formation and preservation • Providing anti-inflammatory and antimicrobial benefits These findings align with our mission to transform oral care through a pharmaceutical approach. By combining the power of statins and antibacterials in PGR-1, we're positioned to tackle periodontitis and other inflammatory conditions more effectively than ever. At TNS, we're driven by our passion for advancing dental innovation. I look forward to sharing more updates as we continue developing cutting-edge solutions for dental professionals and, ultimately, the patients we aim to help. #TuenNodeSciences #OralHealth #Statins #Periodontitis #TNSInnovation #innovation Source:

With today’s medical advancements, major surgeries can often be done with very minimal scarring. Still, unsightly marks permanently on the skin can be incredibly frustrating. No one wants a constant reminder of such traumatic injuries or medical procedures. But, what can you do? Did you know that a new, biodegradable polymer might be the answer? This isn’t a sci-fi script! Today’s products can go a long way to improving and even eliminating the visibility of a scar. Learn more here: https://lnkd.in/eC-mYffF #customcarecompounding #pharmacy #california #healthcare #compoundingpharmacy #holisticmedicine

Have you ever looked into our INCI name? BENEV Exosome products are post-care “topical use” cosmetic solutions. The isolated and purified exosomes in BENEV Exosome products have been accepted by the PCPC and International Cosmetic Ingredient Nomenclature Committee (INC) and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as the INCI book. No other cosmetic INCI names had been assigned to exosome products on the market before this accomplishment. Click the link in our bio to read more about the science behind our BENEV Exosomes! *EXOSOME Disclaimer: BENEV Exosome products powered by Exo-SCRT™ are post care “topical use” cosmetic solutions. The isolated and purified exosomes in both products have been accepted by the PCPC, and International Cosmetic Ingredient Nomenclature Committee (INC), and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as INCI book. There are at this time no other cosmetic INCI name(s) assigned to exosome products in the market prior to this accomplishment. These products are not drug products. They are not intended to prevent, treat or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously. Exosome Regenerative Complex: For Skin, Professional Use, Immediate Post-Treatment Exosome Regenerative Complex +: For Skin & Scalp, Professional Use, Immediate Post-Treatment #benevexosomes #exosomeregenerativecomplex #exosometechnology

We are always about enhancing learning opportunities for our BENEV providers 🩺 and Jonatahn Sigg, PA-C (@jontheinjector) took full advantage during our BENEV in Seoul 2024 trip! Thank you Jonathan, for being a pioneer with our BENEV products and your extensive support of Miracu® PDO threads in your practices! Show him some love! 💜 #benevinseoul #benevfamily #benefiteveryone #sylfirmx #miracupdothreads #benevexosomes #benevcompany *EXOSOME Disclaimer: BENEV Exosome products powered by Exo-SCRT™ are post care “topical use” cosmetic solutions. The isolated and purified exosomes in both products have been accepted by the PCPC, and International Cosmetic Ingredient Nomenclature Committee (INC), and the name ‘Human Adipose Stromal Cell Exosomes’ was given and published in the International Cosmetic Ingredient Dictionary and Handbook, known as INCI book. There are at this time no other cosmetic INCI name(s) assigned to exosome products in the market prior to this accomplishment. These products are not drug products. They are not intended to prevent, treat or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously. *Disclaimer: Sylfirm X is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. (K200185) *Miracu® Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. FDA 510K #K172602. The Miracu barbed surgical suture is comprised of dyed polydioxanone, is indicated for soft tissue approximation where use of an absorbable suture is appropriate. The anatomical locations of use are on the skin for dermatological applications only. The suture is not intended for interior body cavity applications and the suture is not intended for lifting and supporting tissues. *Viviscal Disclaimer: These statements have not been reviewed by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new supplement, especially if you have any pre-existing medical conditions or are taking other medications.

Discoloration of the skin is an effect of both aging but also some skin medications. With compounding pharmacies, patients are offered alternative solutions to the more standard and typical medications offered, as scripts can be tailored for the unique user, and not just broadly offered to the masses. Find out how skin medications can potentially work better for you, when utilizing a compounding pharmacy: https://lnkd.in/gv4QvGZH #customcarecompounding #pharmacy #california #healthcare #compoundingpharmacy #holisticmedicine

Huons Meditech, a medical device company under the Huons Group, is strengthening its competitiveness in the skin booster market by introducing a premium needle for enhanced treatment performance. On the 20th, Huons Meditech (CEO Jinsuk Lee) announced the launch of its new sterile injection needle, the ‘Premium 9-Pin Needle 31G,’ designed to minimize drug leakage and pain during skin booster treatments. https://lnkd.in/gGkvU2GR

Huons Meditech, a medical device company under the Huons Group, is strengthening its competitiveness in the skin booster market by introducing a premium needle for enhanced treatment performance. On the 20th, Huons Meditech (CEO Jinsuk Lee) announced the launch of its new sterile injection needle, the ‘Premium 9-Pin Needle 31G,’ designed to minimize drug leakage and pain during skin booster treatments. https://lnkd.in/g_WDbK3s